Literature DB >> 8876229

On the molecular mechanism of chloroquine's antimalarial action.

D J Sullivan1, I Y Gluzman, D G Russell, D E Goldberg.   

Abstract

Chloroquine is thought to exert its antimalarial effect by preventing the polymerization of toxic heme released during proteolysis of hemoglobin in the Plasmodium digestive vacuole. The mechanism of this blockade has not been established. We incubated cultured parasites with subinhibitory doses of [3H]chloroquine and [3H] quinidine. These [3H]quinoline compounds became associated with hemozoin as assessed by electron microscope autoradiography and subcellular fractionation. In vitro, binding of [3H]quinoline inhibitors to the hemozoin chain depended on the addition of heme substrate. These data counter previous conclusions regarding the lack of quinoline association with hemozoin, explain the exaggerated accumulation of quinolines in the plasmodium digestive vacuole, and suggest that a quinoline heme complex incorporates into the growing polymer to terminate chain extension, blocking further sequestration of toxic heme.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8876229      PMCID: PMC38150          DOI: 10.1073/pnas.93.21.11865

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  The plasmodium digestive vacuole: metabolic headquarters and choice drug target.

Authors:  P L Olliaro; D E Goldberg
Journal:  Parasitol Today       Date:  1995-08

2.  Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites.

Authors:  A F Slater; A Cerami
Journal:  Nature       Date:  1992-01-09       Impact factor: 49.962

3.  Morphological effects of chloroquine on Plasmodium berghei in mice.

Authors:  P B Macomber; H Sprinz
Journal:  Nature       Date:  1967-05-27       Impact factor: 49.962

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The state of ferriprotoporphyrin IX in malaria pigment.

Authors:  C D Fitch; P Kanjananggulpan
Journal:  J Biol Chem       Date:  1987-11-15       Impact factor: 5.157

6.  Comparative analysis of the Plasmodium falciparum histidine-rich proteins HRP-I, HRP-II and HRP-III in malaria parasites of diverse origin.

Authors:  E P Rock; K Marsh; A J Saul; T E Wellems; D W Taylor; W L Maloy; R J Howard
Journal:  Parasitology       Date:  1987-10       Impact factor: 3.234

7.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

8.  A nuclear magnetic resonance study of the interactions of antimalarial drugs with porphyrins.

Authors:  S Moreau; B Perly; C Chachaty; C Deleuze
Journal:  Biochim Biophys Acta       Date:  1985-05-29

9.  Malarial haemozoin/beta-haematin supports haem polymerization in the absence of protein.

Authors:  A Dorn; R Stoffel; H Matile; A Bubendorf; R G Ridley
Journal:  Nature       Date:  1995-03-16       Impact factor: 49.962

10.  A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole.

Authors:  A F Cowman; S Karcz; D Galatis; J G Culvenor
Journal:  J Cell Biol       Date:  1991-06       Impact factor: 10.539

View more
  146 in total

1.  Fate of haem iron in the malaria parasite Plasmodium falciparum.

Authors:  Timothy J Egan; Jill M Combrinck; Joanne Egan; Giovanni R Hearne; Helder M Marques; Skhumbuzo Ntenteni; B Trevor Sewell; Peter J Smith; Dale Taylor; Donelly A van Schalkwyk; Jason C Walden
Journal:  Biochem J       Date:  2002-07-15       Impact factor: 3.857

2.  Hematin polymerization assay as a high-throughput screen for identification of new antimalarial pharmacophores.

Authors:  Y Kurosawa; A Dorn; M Kitsuji-Shirane; H Shimada; T Satoh; H Matile; W Hofheinz; R Masciadri; M Kansy; R G Ridley
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

Review 3.  Schistosomiasis--a century searching for chemotherapeutic drugs.

Authors:  Gabriela Ribeiro-dos-Santos; Sergio Verjovski-Almeida; Luciana C C Leite
Journal:  Parasitol Res       Date:  2006-04-25       Impact factor: 2.289

4.  Computational studies of new potential antimalarial compounds--stereoelectronic complementarity with the receptor.

Authors:  César Portela; Carlos M M Afonso; Madalena M M Pinto; Maria João Ramos
Journal:  J Comput Aided Mol Des       Date:  2003-09       Impact factor: 3.686

5.  Antimalarial 9-anilinoacridine compounds directed at hematin.

Authors:  Saranya Auparakkitanon; Wilai Noonpakdee; Raymond K Ralph; William A Denny; Prapon Wilairat
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

Review 6.  History, dynamics, and public health importance of malaria parasite resistance.

Authors:  Ambrose O Talisuna; Peter Bloland; Umberto D'Alessandro
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

7.  A correlation study of quinoline derivatives and their pharmaceutical behavior by ab initio calculated NQR parameters.

Authors:  Marjan A Rafiee; Nasser L Hadipour; Hossein Naderi-manesh
Journal:  J Comput Aided Mol Des       Date:  2004-03       Impact factor: 3.686

8.  Lipophilic mediated assays for beta-hematin inhibitors.

Authors:  Melissa D Carter; Vanessa V Phelan; Rebecca D Sandlin; Brian O Bachmann; David W Wright
Journal:  Comb Chem High Throughput Screen       Date:  2010-03       Impact factor: 1.339

9.  In vivo splenic clearance correlates with in vitro deformability of red blood cells from Plasmodium yoelii-infected mice.

Authors:  Sha Huang; Anburaj Amaladoss; Min Liu; Huichao Chen; Rou Zhang; Peter R Preiser; Ming Dao; Jongyoon Han
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

10.  Schistosoma mansoni hemozoin modulates alternative activation of macrophages via specific suppression of Retnla expression and secretion.

Authors:  Martha Truscott; D Andrew Evans; Matt Gunn; Karl F Hoffmann
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.